Physician profile
Richard E Seroussi
NPI 1992722698
$398.65
in general payments reported to CMS, 2019-2025
7 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.56 · 2020: $59.89 · 2021: $39.58 · 2022: $71.67 · 2023: $24.76 · 2024: $63.62 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $160.93 | 2020-2023 | Dysport |
| Merz Pharmaceuticals, LLC | $142.59 | 2024-2025 | Xeomin |
| Abbvie INC. | $26.32 | 2025 | |
| Neuronetics, INC. | $20.28 | 2025 | Neurostar Tms Therapy System |
| Mdd US Operations, LLC | $19.23 | 2020 | |
| Abbott Laboratories | $15.74 | 2022 | |
| Medtronic USA, INC. | $13.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Seroussi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.